Phytochemical Name : Tricetin

Properties Information
PhytoCAT-ID PhytoCAT-568
Phytochemical name or plant extracts Tricetin
PMID 19705844
Literature evidence These findings suggest that tricetin may be a promising chemopreventive agent against human breast cancer.
IUPAC name 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
Phytochemicals’ class or type of plant extracts Flavonoid
Source of phytochemicals or plant Extracts Punica granatum
Geographical availability Afghanistan, Iran, Iraq, North Caucasus, Pakistan, Tadzhikistan, Transcaucasus, Turkey, Turkmenistan
Plant parts NA
Other cancers Breast cancer
Target gene or protein Bax, Bak, p21, cdc2, cdc25C, Cyclin B, Bcl-2, Bcl-xL, ABCG2
Gene or Protein evidence Tricetin can inhibit cell cycle progression at the G2/M phase by increasing p21 expression in a p53-dependent manner, and by decreasing the expression of cdc2, cdc25C, and cyclin B. tricetin treatment resulted in a significant increase of Bax and Bak expression, and a decrease of Bcl-2 and Bcl-XL, suggesting that changes in the ratio of the proapoptotic and antiapoptotic Bcl-2 family proteins might contribute to the apoptosis-promotion activity of tricetin. Chrysoeriol, laricitrin, myricetin 3',4',5'-trimethylether, pinocembrin, quercitrin, tamarixetin, tricetin and tricetin 3',4',5'-trimethylether were also identified as novel flavonoid ABCG2 inhibitors.
Target pathways NA
IC50 32.17 μM against MCF-7 cells
Potency These findings suggest that tricetin may be a promising chemopreventive agent against human breast cancer.
Cell line/ mice model MCF-7
Additional information  In addition, pretreatment of cells with caspase-9 inhibitor blocked tricetin-induced apoptosis, indicating that caspase-9 activation is involved in tricetin-mediated MCF-7 cell apoptosis.
PubChem ID 5281701
Additional PMIDs 23497885
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:554129-1
Safety NA